With two new calls for proposals, the AO Innovation Translation Center (AO ITC) offers unique resources for innovators, both in terms of funding and know-how. The support is targeted at ideas for clinical tools and technologies to enhance the patient journey in musculoskeletal disorders, as well as concepts for educational tools, platforms, and channels to support lifelong training for surgeons.
There are two resource streams available. The strategy fund focuses on clinical tools and technologies for any element of the entire patient journey in musculoskeletal disorders, from diagnosis to postoperative care, or educational tools, platforms, or channels for lifelong training of surgeons.
The development incubator supports inventors with funding and know-how. Inventors can apply for investment of up to USD 3 million over five years. Funding is granted by an independent board that approves proposals and consults widely with experts in relevant fields. Approved projects also benefit from valuable know-how in securing intellectual property, developing a proof of concept (POC), and planning valorization of the POC.
These resource streams provide worldwide exceptional opportunities to bring innovative concepts to life while advancing the AO mission of promoting excellence in patient care and outcomes in trauma and musculoskeletal disorders.
"These resource streams provide exceptional opportunities to bring innovative concepts to life."
The AO ITC streamlines and drives innovation projects, with activities ranging from the development of clinical solutions with industrial partners, innovation gathering, and proof-of-concept studies with innovators, to strategic investment in intellectual property, technology, or companies, and evidence creation through clinical research. As part of the AO ITC, the Technology Transfer office drives innovation by making strategic investment, providing AO Technical Commission off-ramp projects, and delivering innovation projects together with external partners.
We encourage you to take advantage of these opportunities and advance the care an outcomes of spine patients around the world with us.
